Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist

Clinical trial NCT02738151 · COMPLETED

Trial details

NCT number

NCT02738151

Sponsor

Sanofi

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2016-05-19

Primary completion

2017-08-15

Enrollment

929

View on ClinicalTrials.gov